00911 QIANHAI HEALTH
- 0.320
- 0.0000.00%
QIANHAI HEALTH News
Qianhai Health Completes Major Share Consolidation
Qianhai Health (00911) cuts 1,525 billion shares due to share consolidation on a “10 and 1” basis
According to the Zhitong Finance App, Qianhai Health (00911) issued an announcement to reduce 1,525 billion shares due to share consolidation on a “10 and 1” basis.
Qianhai Health (00911) will adjust the exercise price of share options that have not yet been exercised
Qianhai Health (00911) issued an announcement. Due to the share merger taking effect, according to the terms of the share option plan, the company must not yet...
Qianhai Health (00911) is accused of not fulfilling payment obligations under certain procurement contracts and letters of guarantee
Qianhai Health (00911) issued an announcement. On May 6, 2024, a subsidiary of the company received the Beijing No. 1...
前海健康：2023年報
Qianhai Health (00911.HK) proposes to adopt the 2024 share option plan
Gelonghui, April 26, 丨 Qianhai Health (00911.HK) announced the adoption of the 2024 share option plan. The purpose of the 2024 share option plan is to (i) enable the company to grant share options to eligible participants as a reward or reward for their contributions to the Group's growth and development; (ii) attract and retain talents to promote the Group's sustainable development; and (iii) align the interests of grantees with the interests of shareholders to promote the company's long-term financial and business performance.
QIANHAI HEALTH To Carry Out 1-for-10 Reverse Stock Split On May 20th, 2024
April 18th - $QIANHAI HEALTH(00911.HK)$ is about to implement a 1-for-10 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from May 20th, 2024.$QIANHAI HEALTH(0091
Qianhai Health (00911.HK) proposes to change the trading unit for each “10 in 1” merger to 10,000 shares
Gelonghui April 17 丨 Qianhai Health (00911.HK) issued an announcement. The board of directors proposed a “10 in 1” share merger. The share consolidation is subject to shareholders' approval at the special shareholders' meeting before it can actually take place. The board of directors proposed changing the trading unit for each lot to be traded on the Stock Exchange from 5,000 existing shares to 10,000 consolidated shares after the share merger comes into effect.
Qianhai Health (00911) plans to implement a “10 merge 1” share merger
Qianhai Health (00911) issued an announcement. The board of directors recommended a face value of HK$0.04 per 10 shares already issued and...
Qianhai Health's Loss Shrinks in 2023
Qianhai Health Holdings (HKG:0911) saw a decline in attributable loss for the year ended Dec. 31, 2023, to HK$52.7 million from HK$233.7 million in 2022, according to a filing with the Hong Kong bours
Qianhai Health (00911) announces 2023 annual results. Shareholders' loss of HK$52.755 million during the year narrowed by 77.45% year-on-year
Qianhai Health (00911) announced its annual results for the year ended December 31, 2023. The group made profits during the period...
前海健康：截至二零二三年十二月三十一日止年度的 年度業績公告
Qianhai Health (00911.HK) expects annual losses to be reduced by about 77%
On February 8, GLONGHUI | Qianhai Health (00911.HK) announced that the company expects to record losses of about 77% for the year ended December 31, 2023, and recorded a loss of about HK$233.7 million compared to the previous year. Despite a decrease in the average sales price (lower than inventory price) and sales volume of electronic components sold by the Group this year, which led to a decrease in the Group's total revenue and recorded gross loss (gross profit recorded in the previous year), the Group expects to record a decrease in losses this year. This improvement was mainly due to a slight rebound in the average semiconductor sales price in the last quarter of this year, resulting in no confirmed inventory or loss contracts this year
QIANHAI HEALTH: INSIDE INFORMATION - EXPECTED DECREASE IN LOSS
Qianhai Health Proposes Cooperation With LiZhiXi Health Management for Product Sales
Qianhai Health Holdings (HKG:0911), through subsidiary Qianhai Health, signed a letter of intent of strategic cooperation with Shenzhen LiZhiXi Health Management for the sale of healthcare products an
QIANHAI HEALTH: 2023 INTERIM REPORT
QIANHAI HEALTH: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2023
QIANHAI HEALTH: DATE OF BOARD MEETING
Qianhai Health Flags HK$110 Million Loss for H1
Qianhai Health Holdings (HKG:00911) expects to turn to a net loss attributable to shareholders of HK$110 million in the first-half of 2023, against a net profit of about HK$20 million a year ago. The
Qianhai Health Expects to Post Losses for 1H
Qianhai Health Expects to Post Losses for 1H
Analysis
Price Target
No Data
